share_log

Morgan Stanley Reiterates Equal-Weight on Nautilus Biotechnology, Maintains $6 Price Target

Benzinga ·  Aug 3, 2023 11:22

Morgan Stanley analyst Tejas Savant reiterates Nautilus Biotechnology (NASDAQ:NAUT) with a Equal-Weight and maintains $6 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment